ConvaTec Group PLC Director/PDMR Shareholding (3442N)

TIDMCTEC

RNS Number : 3442N

ConvaTec Group PLC

19 May 2020

19 May 2020

ConvaTec Group Plc

("ConvaTec" or "the Company")

Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 14 May 2020, Mr Rick Anderson, Non-Executive Director and a PDMR, acquired 1,322 Shares at GBP1.7972 per share under the Scrip Dividend Scheme. Mr Anderson's resulting shareholding is 208,590 Shares.

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 
  1      Details of the person discharging managerial responsibilities/person 
          closely associated 
  a)    Name                                              Rick Anderson 
  2     Reason for the notification 
  a)    Position/Status                                   Non-Executive Director 
  b)    Initial notification/Amendment                    Initial notification 
  3     Details of the issuer, emission allowance market participant, 
         auction platform, auctioneer or auction monitor 
  a)    Name                                              ConvaTec Group Plc 
  b)    LEI                                               213800LS272L4FIDOH92 
  4     Details of the transaction(s): section to be repeated for 
         (i) each type of instrument; (ii) each type of transaction; 
         (iii) each date; and (iv) each place where transactions have 
         been conducted 
  a)    Description of the financial                      Ordinary shares of 10p each in ConvaTec Group Plc ("Shares") 
         instrument, type of instrument                    GB00BD3VFW73 
         Identification code 
  b)    Nature of the transaction                          Acquisition of Shares under Scrip Dividend Scheme 
  c)    Price(s) and volume(s)                            Price(s)                                         Volume(s) 
                                                           GBP1.7972                                        1,322 
  d)    Aggregated information 
         - Aggregated volume                                N/A 
         - Price                                            N/A 
  e)    Date of the transaction                           14 May 2020 
  f)    Place of the transaction                          Outside a trading venue 
 
 

Enquiries

Analysts and Investors

Mark Reynolds, Director Investor Relations, ConvaTec [phone]

[e-mail]

Media

Buchanan: Charles Ryland / Chris Lane / Vicky Hayns [phone]

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has established market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Further information can be found at www.convatecgroup.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHFIFVAELIALII

(END) Dow Jones Newswires

May 19, 2020 05:40 ET (09:40 GMT)